AIThe SaaS Newsabout 1 hour ago
Remepy Raises $36M Series A
2 min read
Remepy, a Ramat Gan-based digital health company, closed a $36 million Series A led by OG Venture Partners and M Ventures, bringing total funding to $62 million. The capital will advance Parkinson's candidate Hybridopa into a global Phase III trial starting in Q4 2026.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
